Zoster Vaccination Increases the Breadth of CD4+T Cells Responsive to Varicella Zoster Virus

Risk of Stroke Following Herpes Zoster: A Self-Controlled Case-Series Study

(2014) Sinéad M. Langan et al.   CLINICAL INFECTIOUS DISEASES

Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors

(2014) Anajane G. Smith et al.   HUMAN IMMUNOLOGY

Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections

(2014) Myron J. Levin   JOURNAL OF CLINICAL VIROLOGY

Functional Characterization of Ocular-Derived Human Alphaherpesvirus Cross-Reactive CD4 T Cells

(2014) W. J. D. Ouwendijk et al.   JOURNAL OF IMMUNOLOGY

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

(2014) Peter B. Gilbert et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

(2014) Elchonon M. Berkowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK

(2014) J. Breuer et al.   NEUROLOGY

Varicella Zoster-Specific CD4+Foxp3+ T Cells Accumulate after Cutaneous Antigen Challenge in Humans

(2013) M. Vukmanovic-Stejic et al.   JOURNAL OF IMMUNOLOGY

Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine

(2013) Myron J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age

(2013) R. Chlibek et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults

(2013) Kathleen M. Mullane et al.   JOURNAL OF INFECTIOUS DISEASES

Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection

(2013) Jia Zhu et al.   NATURE

T-cell immunity to human alphaherpesviruses

(2013) Werner JD Ouwendijk et al.   Current Opinion in Virology

Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study

(2013) Sinéad M. Langan et al.   PLOS MEDICINE

Local CD4 and CD8 T-Cell Reactivity to HSV-1 Antigens Documents Broad Viral Protein Expression and Immune Competence in Latently Infected Human Trigeminal Ganglia

(2013) Monique van Velzen et al.   PLoS Pathogens

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

(2012) K. E. Schmader et al.   CLINICAL INFECTIOUS DISEASES

Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine

(2012) Lichen Jing et al.   JOURNAL OF CLINICAL INVESTIGATION

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

(2012) Isabel Leroux-Roels et al.   JOURNAL OF INFECTIOUS DISEASES

Peripheral Blood CD4 T-Cell and Plasmacytoid Dendritic Cell (pDC) Reactivity to Herpes Simplex Virus 2 and pDC Number Do Not Correlate with the Clinical or Virologic Severity of Recurrent Genital Herpes

(2012) Nicholas J. Moss et al.   JOURNAL OF VIROLOGY

Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data

(2012) G.S. Goldman et al.   VACCINE

Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses

(2011) K. J. Laing et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation

(2011) P. Kleemann et al.   HAEMATOLOGICA

Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease

(2011) Hung Fu Tseng   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Varicella-zoster virus human ganglionic latency: a current summary

(2011) Peter GE Kennedy et al.   JOURNAL OF NEUROVIROLOGY

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

(2011) Joost N. Vermeulen et al.   VACCINE

Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors

(2010) G. N. Malavige et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Diversity in CD8+ T Cell Function and Epitope Breadth Among Persons with Genital Herpes

(2010) Kerry J. Laing et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray

(2010) Alessandro Ceroni et al.   Molecular BioSystems

ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans

(2009) Lichen Jing et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The Immune Epitope Database 2.0

(2009) Randi Vita et al.   NUCLEIC ACIDS RESEARCH

Laboratory Diagnosis and Characteristics of Breakthrough Varicella in Children

(2008) Sheila Weinmann et al.   JOURNAL OF INFECTIOUS DISEASES

Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

(2008) M. J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES